Holen Sie sich die Stockscreener-App
0.2428
3.34%
-0.0084
Handel nachbörslich:
.23
-0.0128
-5.27%
Schlusskurs vom Vortag:
$0.2512
Offen:
$0.2546
24-Stunden-Volumen:
3.73M
Relative Volume:
0.22
Marktkapitalisierung:
$2.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.53M
KGV:
-0.0504
EPS:
-4.82
Netto-Cashflow:
$-11.12M
1W Leistung:
+13.99%
1M Leistung:
-7.58%
6M Leistung:
-64.40%
1J Leistung:
-85.38%
1-Tages-Spanne:
$0.238
$0.2546
1-Wochen-Bereich:
$0.2071
$0.2689
52-Wochen-Spanne:
$0.15
$3.10
Processa Pharmaceuticals Inc Stock (PCSA) Company Profile
Firmenname
Processa Pharmaceuticals Inc
Sektor
Branche
Telefon
443-776-3133
Adresse
7380 COCA COLA DRIVE, HANOVER
Vergleichen Sie PCSA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PCSA
Processa Pharmaceuticals Inc
|
0.2428 | 6.58M | 0 | -11.53M | -11.12M | -4.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-25 | Eingeleitet | H.C. Wainwright | Buy |
Processa Pharmaceuticals Inc Aktie (PCSA) Neueste Nachrichten
What analysts say about Processa Pharmaceuticals Inc. stockFree Stock Market Query - PrintWeekIndia
Processa Pharmaceuticals Files Prospectus for Stock Sale - TipRanks
NTLA CFO Sells 7,462 Shares in Tax Withholding Transaction – Form 4 | PCSA SEC FilingForm 424B5 - Stock Titan
Processa Pharmaceuticals Inc. Stock Analysis and ForecastExponential wealth increase - PrintWeekIndia
What drives Processa Pharmaceuticals Inc. stock priceAccelerated profit realization - PrintWeekIndia
When is the best time to buy Processa Pharmaceuticals Inc. stockUnprecedented profit potential - jammulinksnews.com
Is Processa Pharmaceuticals Inc. a good long term investmentConsistent triple-digit returns - jammulinksnews.com
Processa Pharmaceuticals Inc (PCSA) Stock: A Year of Stock Market Dynamics - investchronicle.com
What makes Processa Pharmaceuticals Inc. stock price move sharplyFree Wealth-Building Investment Strategies - Newser
Processa Pharmaceuticals Approves Key Proposals at Annual Meeting - The Globe and Mail
RedChip Showcases Processa Pharmaceuticals and BullFrog AI on Bloomberg TV - AInvest
Processa Pharmaceuticals and BullFrog AI Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Foster's Daily Democrat
The Convergence of AI and Biotech: BullFrog AI and Processa Pharmaceuticals as Catalysts for Disruption - AInvest
How Processa Pharmaceuticals Inc. stock performs during market volatilityTrend Following Trades - Newser
Why Processa Pharmaceuticals Inc. stock attracts strong analyst attentionCarefully Curated High Return Stocks - Newser
Processa Pharmaceuticals Reschedules Annual Shareholder Meeting - TipRanks
Processa Pharmaceuticals to reconvene annual meeting after achieving quorum By Investing.com - Investing.com South Africa
Processa Pharmaceuticals to reconvene annual meeting after achieving quorum - Investing.com
Processa Pharmaceuticals, Inc. (PCSA) Secures Buy Rating on Portfolio Progress - MSN
Processa Pharmaceuticals: Betting on Catalyst-Driven Value Acceleration - AInvest
Finanzdaten der Processa Pharmaceuticals Inc-Aktie (PCSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):